These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 24764572)

  • 1. FDA chief defends Zohydro approval as US states rebel.
    McCarthy M
    BMJ; 2014 Apr; 348():g2939. PubMed ID: 24764572
    [No Abstract]   [Full Text] [Related]  

  • 2. Zohydro approval by food and drug administration: controversial or frightening?
    Manchikanti L; Atluri S; Candido KD; Boswell MV; Simopoulos TT; Grider JS; Falco FJ; Hirsch JA
    Pain Physician; 2014; 17(4):E437-50. PubMed ID: 25054396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic pain, addiction, and Zohydro.
    Olsen Y; Sharfstein JM
    N Engl J Med; 2014 May; 370(22):2061-3. PubMed ID: 24758596
    [No Abstract]   [Full Text] [Related]  

  • 4. Extended-release hydrocodone (Zohydro) for pain.
    Med Lett Drugs Ther; 2014 Jun; 56(1444):45-6. PubMed ID: 24933087
    [No Abstract]   [Full Text] [Related]  

  • 5. US bill would force FDA to withdraw approval of new pain drug Zohydro.
    McCarthy M
    BMJ; 2014 Mar; 348():g2195. PubMed ID: 24637611
    [No Abstract]   [Full Text] [Related]  

  • 6. FDA is urged to reverse its approval of new pain drug Zohydro ER.
    McCarthy M
    BMJ; 2014 Mar; 348():g1894. PubMed ID: 24591422
    [No Abstract]   [Full Text] [Related]  

  • 7. Canadian approval sought for controversial pain drug.
    Brown C
    CMAJ; 2014 May; 186(8):571. PubMed ID: 24664646
    [No Abstract]   [Full Text] [Related]  

  • 8. FDA Approval of Extended-Release Oxycodone for Children With Severe Pain.
    Yang YT; Chen B; Bennett CL
    Pediatrics; 2016 May; 137(5):. PubMed ID: 27244829
    [No Abstract]   [Full Text] [Related]  

  • 9. Did we reach too far? The opioid epidemic and chronic pain.
    Schofferman J; Fishman SM; Harden RN; Kirschner KL
    PM R; 2014 Jan; 6(1):78-84. PubMed ID: 24439150
    [No Abstract]   [Full Text] [Related]  

  • 10. FDA approves oxycodone and acetaminophen extended-release tablets.
    J Pain Palliat Care Pharmacother; 2014 Jun; 28(2):188-9. PubMed ID: 25011144
    [No Abstract]   [Full Text] [Related]  

  • 11. Hydrocodone bitartrate for chronic pain.
    Manchikanti L; Atluri S; Kaye AM; Kaye AD
    Drugs Today (Barc); 2015 Jul; 51(7):415-27. PubMed ID: 26261844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent developments toward the safer use of opioids, with a focus on hydrocodone.
    Covvey JR
    Res Social Adm Pharm; 2015; 11(6):901-8. PubMed ID: 25769501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of FDA approval of a generic competitor to OxyContin (oxycodone HCl controlled-release) tablets on the abuse of oxycodone.
    Bailey JE; Barton PL; Lezotte D; Lowenstein SR; Dart RC
    Drug Alcohol Depend; 2006 Sep; 84(2):182-7. PubMed ID: 16510252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydrocodone extended-release: pharmacodynamics, pharmacokinetics and behavioral pharmacology of a controversy.
    Gould HJ; Paul D
    Pharmacol Res; 2015 Jan; 91():99-103. PubMed ID: 25301538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A morphine/naltrexone combination (Embeda) for pain.
    Med Lett Drugs Ther; 2010 Mar; 52(1334):22-3. PubMed ID: 20336033
    [No Abstract]   [Full Text] [Related]  

  • 16. Abuse-resistant painkillers get mixed FDA response.
    Waters H
    Nat Med; 2011 Aug; 17(8):905. PubMed ID: 21818068
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluating the stability of opioid efficacy over 12 months in patients with chronic noncancer pain who initially demonstrate benefit from extended release oxycodone or hydrocodone: harmonization of Food and Drug Administration patient-level drug safety study data.
    Farrar JT; Bilker WB; Cochetti PT; Argoff CE; Haythornthwaite J; Katz NP; Gilron I
    Pain; 2022 Jan; 163(1):47-57. PubMed ID: 34261978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pain & opioid addiction: hydrocodone update & zohydro. The paradigm for the epidemic..... continues.
    Hall PB
    W V Med J; 2014; 110(6):6-10. PubMed ID: 25651658
    [No Abstract]   [Full Text] [Related]  

  • 19. Both Urgency and Balance Needed in Addressing Opioid Epidemic: A Report From the National Academies of Sciences, Engineering, and Medicine.
    Bonnie RJ; Kesselheim AS; Clark DJ
    JAMA; 2017 Aug; 318(5):423-424. PubMed ID: 28715551
    [No Abstract]   [Full Text] [Related]  

  • 20. REMS; red tape, or a remedy for opioid abuse?
    Porada S
    J Fam Pract; 2011 Sep; 60(9 Suppl):S55-62. PubMed ID: 22442761
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.